News
Extraction
Production
Rapid Dose Therapeutics to manufacture products for OG Laboratories
March 11, 2021 By Grow Opportunity staff
OG CBD Eliquid is marketed as an alternative from nicotine to use in vape devices. (Credit: OG Laboratories via Facebook) Canadian life science company Rapid Dose Therapeutics Corp. has signed a production agreement with OG Laboratories Canada Inc.
Rapid Dose will manufacture OG’s line of cannabis vape and CBD from hemp products for the Canadian market. OG laboratories, which is headquartered in Deerfield Beach, Fla., will provide its formulations, processes, certain technologies and equipment to bring its products to the Canadian market.
“We have experienced demand from Canadians on our website that we were unable to fulfill,” said OG Labs chief executive Nick Trivedi in a company statement. “Through RDT, we can now make our popular aftermarket pods and disposable vaporizers available to Canadian customers. We are also looking forward to bringing continued innovation and new formulations to the market with this partnership with Rapid Dose.”
Rapid Dose Therapeutics is a publicly-traded company that focuses on healthcare manufacturing for the nutraceutical, pharmaceutical and cannabis industries. The company’s headquarters is located in Burlington, Ont.
Print this page
